Manufactured by:ProteoGenix
Save 20%RUO

Anti-CoV-RBD (B5) antibody

Anti-CoV-RBD (B5) antibody from ProteoGenix; catalogue PTXCOV-A521E; research use only.

SKU:
ABM133508-1
Manufacturer SKU
PTXCOV-A521E
Product type
Primary Antibodies
TargetRBD domain- SARS-CoV2 Spike protein
Expression systemMammalian
Purity85%

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

General information on Anti-CoV-RBD (B5) antibody

The anti-CoV-RBD (B5) antibody targets the RBD – receptor-binding domain of the new pandemic strain of coronavirus, SARS-CoV-2. Initially detected in December 2019, the new strain continues to spread unattained causing unimaginable losses. Antibodies have been identified as potential game-changers in the development of life-saving therapies for the COVID-19 disease. Moreover, due to their shorter clinical development times in comparison to vaccines, antibodies can also be used to confer temporary immunity to risk groups such as health care workers, elderly, and immunodeficient individuals.

This specific antibody is a fully human IgG molecule with potential SARS-CoV-2 neutralizing activity, confirmed in competition assays using recombinant forms of the RBD and the ACE2 receptor protein (SARS-CoV-2 Surrogate Virus Neutralization Test, sVNT). Its neutralizing activity can be used to reinforce our knowledge regarding the infection mechanisms of SARS-CoV-2, to assess the potential development of spontaneous escape mutants which would result in lower therapeutic efficiencies, and to detect the presence of SARS-CoV-2 in multiple samples.

The fully human antibody’s specificity and binding affinity have been further tested and validated in ELISA plates (enzyme-linked immunosorbent assay) against the recombinant form of RBD. Additionally, the ease of expression and stability was further confirmed by producing milligram amounts of the recombinant antibody (rAb) in the transient CHO-based mammalian system, XtenCHO™.

ProteoGenix catalogue number PTXCOV-A521E. For research use only.

Target: RBD domain- SARS-CoV2 Spike protein; Clonality: Monoclonal Antibody; Expression system: Mammalian; Purity: 85%; Molecular weight: 150kDa; Buffer: PBS, pH7,5.

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Clonality
Monoclonal
Isotype
IgG1
Source organism
Human
Molecular weight
150kDa
Form / buffer
Liquid
Sequence
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT
Technical note
For research use and in vitro diagnostic only. Not suitable for human use.
Identifiers & database references
Manufacturer SKU
PTXCOV-A521E
UniProt accession
P0DTC2
Storage, stability & shipping
Storage conditions
4°C for short term; -20°c or -80°C for long term
Shipped at
Blue ice (+4°C)
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
£215.00£172.00